Ammonia Solution, Strong

Ammonia Solution, Strong

SCHEMBL28505508

Cc1ccccc1N1CCN(c2ccc3ccn(CCN4CCCC4(C)C)c3n2)CC1.N

nearest known ligand 0.35

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ADRA1B P35368 3/20 0.35
▸ HTR1A P08908 2/20 0.35
▸ PARP1 P09874 2/20 0.34
▸ ADRA1D P25100 2/20 0.33
▸ ADRA1A P35348 2/20 0.33
▸ HTR7 P34969 2/20 0.32
▸ MEN1 O00255 1/20 0.32
▸ KMT2A Q03164 1/20 0.32
▸ CHRM2 P08172 1/20 0.32
▸ ADRA2A P08913 1/20 0.32
▸ ADRA2B P18089 1/20 0.32
▸ HTR2A P28223 1/20 0.32
▸ HTR2C P28335 1/20 0.32
▸ SLC6A4 P31645 1/20 0.32
▸ DRD3 P35462 1/20 0.32
▸ HTR2B P41595 1/20 0.32
▸ NPC1 O15118 2/20 0.32
▸ RAB9A P51151 2/20 0.32
▸ ATM Q13315 1/20 0.32
▸ ALDH1A1 P00352 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Formamide SCHEMBL21274109 0.88 PARP1 (0.36) ADRA1BHTR1APARP1ADRA1DADRA1A
SCHEMBL21281500 0.82 ADRA1A (0.45) ADRA1BHTR1APARP1ADRA1DADRA1A
SCHEMBL21285605 0.81 ADRA1B (0.38) ADRA1BHTR1APARP1ADRA1DADRA1A
SCHEMBL21285495 0.80 PARP1 (0.42) ADRA1BPARP1ADRA1DADRA1AHTR7
SCHEMBL21268787 0.80 PARP1 (0.42) ADRA1BHTR1APARP1ADRA1DADRA1A
SCHEMBL21273937 0.80 ADRA1A (0.37) ADRA1BHTR1APARP1ADRA1DADRA1A
SCHEMBL21274397 0.80 HTR1A (0.37) ADRA1BHTR1APARP1ADRA1DADRA1A
SCHEMBL21273954 0.79 PARP1 (0.45) ADRA1BHTR1APARP1ADRA1DADRA1A
SCHEMBL21281450 0.77 HRH3 (0.42) HRH3SLC18A3
SCHEMBL21268806 0.77 HRH3 (0.42) HRH3SLC18A3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-112105357-A Pharmaceutically acceptable 6,5 heterobicyclic derivatives UCB生物制药有限责任公司 2020-12-18 — — CN claimed
CN-112105357-A Pharmaceutically acceptable 6,5 heterobicyclic derivatives UCB生物制药有限责任公司 2020-12-18 — — CN disclosed
Send feedback